Catheter Precision (VTAK) to Release Quarterly Earnings on Friday

Catheter Precision (NYSEAMERICAN:VTAK) is projected to issue its quarterly earnings data before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Stock Up 1.5 %

NYSEAMERICAN VTAK opened at $0.38 on Friday. The company has a 50 day moving average price of $0.40. Catheter Precision has a 1-year low of $0.30 and a 1-year high of $8.40. The company has a quick ratio of 0.65, a current ratio of 0.66 and a debt-to-equity ratio of 0.12.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.